MarcGOdrichMD
Ophthalmology • Charlottesville, VACornea & External Disease, Refractive Surgery
Associate Professor
Dr. Odrich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 Jefferson Park Ave
Charlottesville, VA 22903Phone+1 434-924-5485Fax+1 434-244-9436
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 1988 - 1990
New York Presbyterian Hospital (Columbia Campus)Residency, Ophthalmology, 1985 - 1988
Danbury HospitalInternship, Internal Medicine, 1984 - 1985
Columbia University Vagelos College of Physicians and SurgeonsClass of 1984
Certifications & Licensure
VA State Medical License 2016 - 2026
NY State Medical License 1985 - 2021
CT State Medical License 1985 - 2006
MA State Medical License 1988 - 2003- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2015-2022
- New York Magazine Top Doctor New York Magazine, 2015
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 44 citationsCorneal edema resolution after descemetorhexisRichard E. Braunstein, Suzanna Airiani, Margaret A Chang, Marc G Odrich
Journal of Cataract and Refractive Surgery. 2003-07-01 - 13 citationsLacritin proteoforms prevent tear film collapse and maintain epithelial homeostasis.Georgi As. Georgiev, Mohammad Sharifian Gh., Jeff Romano, Karina Luiza Dias Teixeira, Craig Struble
The Journal of Biological Chemistry. 2021-01-01 - 2 citationsLacripep for the Treatment of Primary Sjögren-Associated Ocular Surface Disease: Results of the First-In-Human Study.Joseph Tauber, Gordon W Laurie, Edward C Parsons, Marc G Odrich,
Cornea. 2023-07-01
Press Mentions
Chief Medical OfficerMay 25th, 2022
Professional Memberships
- Fellow
Industry Relationships
- Consultant, Johnson and Johnson VisionDisclosure: Paid Consultant2017 - Present
- Chief Medical Officer, LENZ Therapeutics, Inc.Novel drop for presbyopia in Phase 3 clinical trialDisclosure: FI2016 - Present
- Chief Medical Officer, TearSolutions, Inc.Novel Dry Eye Therapy in Clinical TrialsDisclosure: FI2016 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
